Familial association of histology specific breast cancers with cancers at other sites

被引:7
作者
Bermejo, JL
Hemminki, K
机构
[1] DKFZ, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany
[2] Karolinska Inst, Dept Biosci, Novum, Huddinge, Sweden
关键词
familial risk; sibling risk; breast cancer histology; comedo breast cancer; medullary breast cancer;
D O I
10.1002/ijc.11713
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Breast cancer histologies show important differences in their incidence pattern, method of detection and management. Aggregation of breast cancer occurs also in families diagnosed for cancer at sites different from the breast. Therefore, the familial association of histology specific breast cancers with cancers at other sites is of great interest. The nationwide Swedish Family-Cancer Database was used to calculate standardised incidence ratios (SIRs) for breast cancer when parents or sibling were diagnosed with cancer at the most common sites. Significant SIRs were found when parents had breast, ovarian, laryngeal, endometrial, prostate, lung and colon cancers. If women were diagnosed before the age of 50 years, the SIRs were significant when parents were diagnosed with breast, ovarian, and prostate cancers, and leukaemia, and when siblings were diagnosed with squamous cell skin, pancreatic, breast and endometrial cancers. If mothers were diagnosed with breast cancer, histology-specific SIRs were ranked as comedo > tubular > ductal > lobular; SIR for medullary carcinoma was not significant but it was high when mothers presented with ovarian cancer. Other associations were between the upper aerodigestive tract and lobular, colon and comedo, larynx and ductal cancer. Moreover, cervical cancer was associated with comedo and endometrial cancer with the medullary histology. In conclusion, histology-specific breast cancers were associated with specific cancer sites and the strength of the association varied among histologies. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:430 / 435
页数:6
相关论文
共 54 条
[1]
Alcohol, tobacco and breast cancer -: collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95067 women without the disease [J].
Beral, V ;
Hamajima, N ;
Hirose, K ;
Rohan, T ;
Calle, EE ;
Heath, CW ;
Coates, RJ ;
Liff, JM ;
Talamini, R ;
Chantarakul, N ;
Koetsawang, S ;
Rachawat, D ;
Morabia, A ;
Schuman, L ;
Stewart, W ;
Szklo, M ;
Bain, C ;
Schofield, F ;
Siskind, V ;
Band, P ;
Coldman, AJ ;
Gallagher, RP ;
Hislop, TG ;
Yang, P ;
Kolonel, LM ;
Nomura, AMY ;
Hu, J ;
Johnson, KC ;
Mao, Y ;
De Sanjose, S ;
Lee, N ;
Marchbanks, P ;
Ory, HW ;
Peterson, HB ;
Wilson, HG ;
Wingo, PA ;
Ebeling, K ;
Kunde, D ;
Nishan, P ;
Hopper, JL ;
Colditz, G ;
Gajalakshmi, V ;
Martin, N ;
Pardthaisong, T ;
Solpisornkosol, S ;
Theetranont, C ;
Boosiri, B ;
Chutivongse, S ;
Jimakorn, P ;
Virutamasen, P .
BRITISH JOURNAL OF CANCER, 2002, 87 (11) :1234-1245
[2]
CLAUS EB, 1993, CANCER, V71, P147, DOI 10.1002/1097-0142(19930101)71:1<147::AID-CNCR2820710124>3.0.CO
[3]
2-V
[4]
Di Leo A., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P1
[5]
Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations [J].
Dite, GS ;
Jenkins, MA ;
Southey, MC ;
Hocking, JS ;
Giles, GG ;
McCredie, MRE ;
Venter, DJ ;
Hopper, JL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (06) :448-457
[6]
Dong CH, 2001, INT J CANCER, V92, P144
[7]
Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13 [J].
Easton, DF ;
Steele, L ;
Fields, P ;
Ormiston, W ;
Averill, D ;
Daly, PA ;
McManus, R ;
Neuhausen, SL ;
Ford, D ;
Wooster, R ;
CannonAlbright, LA ;
Stratton, MR ;
Goldgar, DE .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (01) :120-128
[8]
Easton DF, 1996, INT J CANCER, V65, P284, DOI 10.1002/(SICI)1097-0215(19960126)65:3&lt
[9]
284::AID-IJC2&gt
[10]
3.0.CO